SCHEMBL606580

SCHEMBL606580

OCc1cnc(Br)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3229408 0.81
SCHEMBL1419766 0.78 HDAC1 (0.35)
SCHEMBL1639997 0.77
SCHEMBL7989729 0.75
SCHEMBL27834400 0.75
SCHEMBL2090380 0.75
SCHEMBL855873 0.75
SCHEMBL2956791 0.75
SCHEMBL6234352 0.75
SCHEMBL281998 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483440-A A kind of preparation method of 2- (the bromo- 1,3- thiazole -5- base of 2-) acetonitrile SHANGHAI RAISE CHEMICAL TECH CO LTD 2019-11-22 CN claimed
EP-1007517-B1 PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLTHIAZOLES ABBOTT LAB (US) 2003-10-08 EP claimed
EP-1007517-A1 PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLTHIAZOLES Abbott Laboratories (US) 2000-06-14 EP claimed
WO-1999011636-A1 PROCESS FOR THE PREPARATION OF 5-HYDROXYMETHYLTHIAZOLES ABBOTT LABORATORIES (US) 1999-03-11 WO claimed
US-20260042747-A1 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF ALIVEXIS, INC. (JP) 2026-02-12 US disclosed
US-20250340546-A1 HSD17B13 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2025-11-06 US disclosed
EP-4085057-B1 PYRIDINE AND PYRIMIDINE DERIVATIVES USEFUL AS PQSR INVERSE AGONISTS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-10-08 EP disclosed
US-12421222-B2 Substituted quinazolines as HDAC6 inhibitors AUGUSTINE THERAPEUTICS (BE) 2025-09-23 US disclosed
US-12410210-B2 Neuroactive steroids and their methods of use SAGE THERAPEUTICS, INC. (US) 2025-09-09 US disclosed
EP-4565575-A1 KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF Alivexis, Inc. (JP) 2025-06-11 EP disclosed
US-20250154194-A1 NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS, INC. 2025-05-15 US disclosed
US-20250145604-A1 COMPOUNDS AND USE THEREOF AS HDAC6 INHIBITORS AUGUSTINE THERAPEUTICS (BE) 2025-05-08 US disclosed
WO-2008061795-A2 N- (METHYL) -1H- PYRAZOL- 3 -AMINE, N- (METHYL) -PYRIDIN-2-AMINE AND N- (METHYL) -THIAZ0L-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S AC IMMUNE SA (CH) 2008-05-29 WO disclosed
WO-2008057336-A2 HETEROCYCLYL-SUBSTITUTED ANTI-HYPERCHOLESTEROLEMIC COMPOUNDS MERCK & CO., INC. (US) 2008-05-15 WO disclosed
US-7304087-B2 1-acyl-pyrrolidine derivatives for the treatment of viral infections GLAXO GROUP LIMITED (GB) 2007-12-04 US disclosed
WO-2007002557-A1 NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 2007-01-04 WO disclosed
US-20060258720-A1 1-Acyl-pyrrolidine derivatives for the treatment of viral infections GLAXO GROUP LIMITED (GB) 2006-11-16 US disclosed
CN-1732165-A 1-acyl-pyrrolidine derivatives for the treatment of viral infections GLAXO GROUP LTD (GB) 2006-02-08 CN disclosed
EP-1554274-A1 1-ACYL-PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS GLAXO GROUP LIMITED (GB) 2005-07-20 EP disclosed
WO-2004037818-A1 1-ACYL-PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS GLAXO GROUP LIMITED (GB) 2004-05-06 WO disclosed